<SEC-DOCUMENT>0000947871-23-000807.txt : 20230802
<SEC-HEADER>0000947871-23-000807.hdr.sgml : 20230802
<ACCEPTANCE-DATETIME>20230802163118
ACCESSION NUMBER:		0000947871-23-000807
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20230802
DATE AS OF CHANGE:		20230802
EFFECTIVENESS DATE:		20230802

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-273611
		FILM NUMBER:		231136233

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ss2300944_s8.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>As filed with the Securities and Exchange Commission
on August 2, 2023</B></P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 0; text-align: right"><B>Registration No. 333-</B></P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0 0.5in 0 0; text-align: right">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: black 0.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES </B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM S-8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REGISTRATION STATEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNDER THE SECURITIES ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CVS HEALTH
CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Delaware<BR>
    </B>(State or other jurisdiction of</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">incorporation or organization)</P></TD>
    <TD STYLE="width: 33%; font: 12pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 33%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>05-0494040</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(I.R.S. Employer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Identification No.)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>One CVS Drive<BR>
Woonsocket, RI 02895</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address, including Zip Code, of Principal Executive
Offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Signify Health, Inc.
2021 Long-Term Incentive Plan<BR>
</B></FONT><FONT STYLE="font-size: 10pt">(Full title of the plan)</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Shawn M. Guertin<BR>
Executive Vice President and Chief Financial Officer<BR>
CVS Health Corporation<BR>
One CVS Drive<BR>
Woonsocket, RI 02895</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(401) 765-1500</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Name, address and telephone number, including area
code, of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>With a copy to</I></B>:</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Doreen E. Lilienfeld, Esq.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Shearman &amp; Sterling LLP </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>599 Lexington Avenue</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>New York, NY 10022 </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(212) 848-7171</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &ldquo;large
accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo;
in Rule 12b-2 of the Exchange Act.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Large accelerated filer</P></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#254;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Accelerated filer</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">Non-accelerated filer</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Smaller reporting company</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Emerging growth company</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="4"><FONT STYLE="font-size: 10pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">This Registration Statement on Form S-8 (the &ldquo;Registration
Statement&rdquo;) relates to shares of common stock, par value $0.01 per share (&ldquo;CVS Health Stock&rdquo;), of CVS Health Corporation,
a Delaware corporation (the &ldquo;Company&rdquo;), that are reserved and available for issuance pursuant to future awards under the <FONT STYLE="background-color: white">Signify
Health, Inc. 2021 Long-Term Incentive Plan, as amended (the &ldquo;Plan&rdquo;), which Plan was assumed by the Company in connection with
the Company&rsquo;s </FONT>acquisition of <FONT STYLE="background-color: white">Signify Health, Inc. (&ldquo;Signify&rdquo;). T</FONT>he
Company previously registered on Form S-8 shares of CVS Health Stock issuable in respect of certain outstanding and unvested Signify equity
awards that were assumed by the Company and converted into equity awards with respect to shares of CVS Health Stock. The Company is filing
this Registration Statement to register the number of shares reserved and available for issuance pursuant to future awards under the Plan.
The number of shares of CVS Health Stock being registered on this Registration Statement is based on the number of shares of class A common
stock, par value $0.01 per share, of Signify that were reserved and available for issuance pursuant to future awards under the Plan as
of March 29, 2023, as adjusted on the same basis as the assumed Signify equity awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PART I<BR>
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The documents containing the information specified
in Part I of Form S-8 will be sent or given to the participants in the Plan covered by this Registration Statement as required by Rule
428(b)(1) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). Such documents are not required to be filed
with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) either as part of this Registration Statement or as a prospectus
or prospectus supplement pursuant to Rule 424 under the Securities Act. These documents and the documents incorporated by reference in
this Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a prospectus that
meets the requirements of Section 10(a) of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PART II<BR>
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt"><B>Item 3.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Incorporation of Documents by Reference.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The following documents filed with the Commission by
the Company pursuant to the Securities Act and the Securities Exchange Act of 1934, as amended (the &ldquo;1934 Act&rdquo;), are incorporated
herein by reference:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the Company&rsquo;s Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm">Form 10-K</A> for the fiscal year ended December 31, 2022, filed with the Commission on February 8, 2023, and any amendment thereto (the &ldquo;2022 Form 10-K&rdquo;), except to the extent superseded by the Company&rsquo;s Current Report on Form 8-K filed with the Commission on May 25, 2023, relating
to the realigned composition of the Company&rsquo;s segments; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the Company&rsquo;s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023, filed with the Commission on August 2, 2023, and any amendment thereto;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the Company&rsquo;s Current Reports on Form 8-K filed with the Commission since December 31, 2022 (other than portions of those documents furnished or otherwise not deemed to be filed); and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the description of the Company&rsquo;s capital stock contained in the Company&rsquo;s Registration Statement on Form S-4, filed with the Commission on <A HREF="https://www.sec.gov/Archives/edgar/data/64803/000119312518002957/0001193125-18-002957-index.htm">January 4, 2018</A>, including any amendments or supplements thereto, including <A HREF="https://www.sec.gov/Archives/edgar/data/64803/000119312518021755/0001193125-18-021755-index.htm">Amendment No. 1</A> filed on January 26, 2018, <A HREF="https://www.sec.gov/Archives/edgar/data/64803/000119312518031585/0001193125-18-031585-index.htm">Amendment No. 2</A> filed on February 5, 2018 and <A HREF="https://www.sec.gov/Archives/edgar/data/64803/000119312518036987/0001193125-18-036987-index.htm">Amendment No. 3</A> filed on February 9, 2018, as updated by Exhibit 4.21 to the 2022 Form 10-K, together with any amendment or report filed for the purpose of updating such description.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-indent: 0.5in">In addition, all documents subsequently filed by
the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the 1934 Act, prior to the filing of a post-effective amendment to this
Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold,
shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of
such documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">Any statement contained herein or in a document all or a portion of which is incorporated or deemed to be incorporated
by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement
contained herein (or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein)
modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt"><B>Item 4.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Description of Securities.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt"><B>Item 5.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Interests of Named Experts and Counsel.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt"><B>Item 6.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Indemnification of Directors and Officers</B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Section 102(b)(7) of the Delaware General Corporation
Law (the &ldquo;DGCL&rdquo;), permits a corporation to provide in its certificate of incorporation that a director or officer of the corporation
shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director
or officer, provided that such provisions shall not eliminate or limit the liability of (i) a director or officer for any breach of the
director&rsquo;s or officer&rsquo;s duty of loyalty to the corporation or its stockholders, (ii) a director or officer for acts or omissions
not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) a director under Section 174 of the DGCL,
(iv) for any transaction from which the director or officer derived an improper personal benefit, or (v) an officer in any action by or
in the right of the corporation. No such provision shall eliminate or limit the liability of a director or officer for any act or omission
occurring before the date when such provision becomes effective. The Company&rsquo;s Restated Certificate of Incorporation (the &ldquo;Company
Charter&rdquo;) limits the personal liability of a director to the Company and its stockholders for monetary damages for a breach of fiduciary
duty as a director to the fullest extent permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Section 145 of the DGCL provides that a corporation
may indemnify directors and officers as well as other employees and individuals against expenses (including attorneys&rsquo; fees), judgments,
fines and amounts paid in settlement actually and reasonably incurred by such person in connection with any threatened, pending or completed
actions, suits or proceedings in which such person is made a party by reason of such person being or having been a director, officer,
employee or agent of the Company. The DGCL provides that Section 145 is not exclusive of other rights to which those seeking indemnification
may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise. Expenses, including attorneys&rsquo;
fees, incurred by any such person in defending any such action, suit or proceeding shall be paid or reimbursed by the Company in advance
of the final disposition of such action, suit or proceeding upon receipt by the Company of an undertaking of such person to repay such
expenses if it shall ultimately be determined that such person is not entitled to be indemnified by the Company. The Company Charter provides
for indemnification of directors and officers of the Company against liability they may incur in their capacities as such to the fullest
extent permitted under the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The directors and officers of the Company are insured
under a policy of directors&rsquo; and officers&rsquo; liability insurance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt"><B>Item 7.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Exemption from Registration Claimed.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt"><B>Item 8.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Exhibits.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U></U> <U></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px"><U>Exhibit No.</U></TD>
    <TD><U>Exhibit Description</U></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/64803/000119312518184593/d456958dex31c.htm">Restated Certificate of Incorporation of the Company dated June 4, 2018 (incorporated by reference to Exhibit 3.1C to the Company&rsquo;s Current Report on Form 8-K filed on June 5, 2018).</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt">4.2</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/64803/000094787122001199/ss1535680_ex0301.htm">By-Laws of the Company, as amended and restated November 17, 2022 (incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Current Report on Form 8-K filed on November 21, 2022).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">5.1*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="ss2300944_ex0501.htm">Opinion of Shearman &amp; Sterling LLP.</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>15*</TD>
    <TD><A HREF="ss2300944_ex15.htm">Letter of Acknowledgment from Ernst &amp; Young LLP re: Unaudited Interim Financial Information</A>.</P>
</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt">23.1*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="ss2300944_ex2301.htm">Consent of Ernst &amp; Young LLP.</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt">23.2*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="ss2300944_ex0501.htm">Consent of Shearman &amp; Sterling LLP (contained in the Opinion Filed as Exhibit 5.1).</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt">24.1*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#Powerofattorney">Power of Attorney (included on the signature pages).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">99.1*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="ss2300944_ex9901.htm">Signify Health, Inc. 2021 Long-Term Incentive Plan, as amended.</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">107.1*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="ss2300944_ex1071.htm">Filing Fee Table.</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt">____________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">*Filed herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt"><B>Item 9.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Undertakings</B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(a) The undersigned registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">To include any prospectus required by Section 10(a)(3) of the Securities Act;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective Registration Statement; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><I>provided</I>, <I>however</I>, that paragraphs (a)(1)(i) and
(a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports
filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the 1934 Act that are incorporated
by reference in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant&rsquo;s annual report pursuant to Section 13(a) or Section 15(d) of the 1934 Act (and, where applicable, each filing of an employee benefit plan&rsquo;s annual report pursuant to Section 15(d) of the 1934 Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">&nbsp;<BR STYLE="clear: both"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 6pt; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Pursuant to the requirements of the Securities Act
of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing
on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the City of Woonsocket, State of Rhode Island, on the 2nd day of August, 2023.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 5%; font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 35%; font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">CVS Health Corporation</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; font: 12pt Times New Roman, Times, Serif; text-indent: -12pt">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; font: 12pt Times New Roman, Times, Serif; text-indent: -12pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;<FONT STYLE="font-size: 10pt">/s/&nbsp;Shawn M. Guertin</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; font: 12pt Times New Roman, Times, Serif; text-indent: -12pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;Shawn M. Guertin</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Executive Vice President and Chief</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Financial Officer</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="Powerofattorney"></A>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">KNOW ALL PERSONS BY THESE PRESENTS, that each person
whose signature appears below constitutes and appoints each of Shawn M. Guertin and Colleen M. McIntosh as his or her true and lawful
attorney-in-fact and agent, upon the action of either such appointee, with full power of substitution and resubstitution, to do any and
all acts and things and execute, in the name of the undersigned, any and all instruments which each of said attorneys-in-fact and agents
may deem necessary or advisable in order to enable CVS Health Corporation to comply with the Securities Act of 1933, as amended (the &ldquo;Securities
Act&rdquo;), and any requirements of the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) in respect thereof, in connection
with the filing with the Commission of this Registration Statement under the Securities Act, including specifically, but without limitation,
power and authority to sign the name of the undersigned to such Registration Statement, and any amendments to such Registration Statement
(including post-effective amendments), and to file or cause to be filed the same with all exhibits thereto and other documents in connection
therewith with the Commission, to sign any and all applications, registration statements, notices or other documents necessary or advisable
to comply with applicable state securities laws, and to file or cause to be filed the same, together with other documents in connection
therewith with the appropriate state securities authorities, granting unto each of said attorneys-in-fact and agents full power and authority
to do and to perform each and every act and thing requisite or necessary to be done in and about the premises, as fully and to all intents
and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that each of said attorneys-in-fact and
agents may lawfully do or cause to be done by virtue of this Power of Attorney.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Pursuant to the requirements of the Securities Act
of 1933, as amended, this Registration Statement has been signed on the 2nd day of August, 2023 by the following persons in the following
capacities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 36%; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt"><U>Signature</U></FONT></TD>
    <TD STYLE="vertical-align: top; width: 51%; padding-left: 9pt"><FONT STYLE="font-size: 10pt"><U>Title</U></FONT></TD>
    <TD STYLE="width: 13%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;<FONT STYLE="font-size: 10pt">/s/ Fernando Aguirre</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Fernando Aguirre</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;<FONT STYLE="font-size: 10pt">/s/ Jeffrey R. Balser, M.D., Ph.D.</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Jeffrey R. Balser, M.D., Ph.D.</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;<FONT STYLE="font-size: 10pt">/s/ C. David Brown II</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">C. David Brown II</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;<FONT STYLE="font-size: 10pt">/s/ James D. Clark</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Senior Vice President &ndash; Controller and Chief Accounting Officer (Principal Accounting Officer)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">James D. Clark</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;<FONT STYLE="font-size: 10pt">/s/ Alecia A. DeCoudreaux</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Alecia A. DeCoudreaux</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 36%; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt"><U></U></FONT></TD>
    <TD STYLE="vertical-align: top; width: 51%; padding-left: 9pt"><FONT STYLE="font-size: 10pt"><U></U></FONT></TD>
    <TD STYLE="width: 13%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;<FONT STYLE="font-size: 10pt">/s/ Nancy-Ann M. DeParle</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Nancy-Ann M. DeParle</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;<FONT STYLE="font-size: 10pt">/s/ Roger N. Farah</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Chair of the Board and Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Roger N. Farah</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;<FONT STYLE="font-size: 10pt">/s/ Anne M. Finucane</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Anne M. Finucane</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;<FONT STYLE="font-size: 10pt">/s/ Shawn M. Guertin</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Executive Vice President and Chief Financial Officer (Principal Financial Officer)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Shawn M. Guertin</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;<FONT STYLE="font-size: 10pt">/s/ Edward J. Ludwig</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Edward J. Ludwig</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;<FONT STYLE="font-size: 10pt">/s/ Karen S. Lynch</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">President and Chief Executive Officer (Principal Executive Officer) and Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Karen S. Lynch</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;<FONT STYLE="font-size: 10pt">/s/ Jean-Pierre Millon</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Jean-Pierre Millon</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;/s/ <FONT STYLE="font-size: 10pt">Mary L. Schapiro</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Mary L. Schapiro</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ss2300944_ex0501.htm
<DESCRIPTION>OPINION OF SHEARMAN & STERLING LLP
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 5.1 </B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="LOGO" STYLE="height: 12px; width: 247px"></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center">599 Lexington Avenue</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">New York, NY 10022-6069</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">+1.212.848.4000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0; text-align: right">August 2, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">CVS Health Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">One CVS Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Woonsocket, RI 02895</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-indent: 24.5pt">We are acting as counsel for CVS Health Corporation,
a Delaware corporation (the &#8220;<U>Company</U>&#8221;), in connection with preparation and filing by the Company of a registration
statement on Form S-8 (the &#8220;<U>Registration Statement</U>&#8221;) with the Securities and Exchange Commission under the Securities
Act of 1933, as amended (the &#8220;<U>Securities Act</U>&#8221;), with respect to 9,234,836 shares of common stock, par value $0.01,
of the Company (the &#8220;<U>Shares</U>&#8221;) that may be delivered from time to time pursuant to the Signify Health, Inc. 2021 Long-Term
Incentive Plan, as amended (the &#8220;<U>Plan</U>&#8221;). In connection with the foregoing, we have reviewed originals or copies identified
to our satisfaction of the following documents:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-indent: 24.5pt">(a) The Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">(b) The certificate of incorporation and bylaws
of the Company, in each case as amended to date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">(c) Originals or copies of such other corporate
records of the Company, certificates of public officials and of officers of the Company, and agreements and other documents as we have
deemed necessary as a basis for the opinions expressed below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">In our examination, we have assumed the genuineness
of all signatures, the authenticity of all documents, certificates and instruments submitted to us as originals and the conformity with
originals of all documents submitted to us as copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">Our opinion set forth below is based on the
text of the Plan as referenced in the Exhibit Index to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">Our opinion expressed below is limited to the
General Corporation Law of the State of Delaware, and we do not express any opinion herein concerning any other law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">Based upon and subject to the foregoing and
having regard for such legal considerations as we have deemed relevant, we are of the opinion that authorized but not previously issued
Shares that may be delivered under the Plan have been duly authorized by the Company and, when (a) issued and delivered by the Company
in accordance with the terms of the Plan and (b) paid for in full in accordance with the terms of the Plan, will be validly issued, fully
paid and non-assessable.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">This opinion letter speaks only as of the date
hereof. We expressly disclaim any responsibility to advise you of any development or circumstance of any kind, including any change of
law or fact that may occur after the date of this opinion letter that might affect the opinions expressed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">We hereby consent to the filing of this opinion
as an exhibit to the Registration Statement. In giving this consent, we do not thereby concede that we come within the category of persons
whose consent is required by the Securities Act or the General Rules and Regulations of the Securities and Exchange Commission promulgated
thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></P>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 24%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 100%">&nbsp;<FONT STYLE="font-size: 10pt">/s/ Shearman &amp; Sterling LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">Shearman &amp; Sterling LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15
<SEQUENCE>3
<FILENAME>ss2300944_ex15.htm
<DESCRIPTION>LETTER OF ACKNOWLEDGMENT FROM ERNST & YOUNG LLP
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 15</B></P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">August 2, 2023</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">To the Shareholders and the Board of Directors of CVS Health Corporation</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; font: 11pt Times New Roman, Times, Serif">We are aware of the incorporation by reference in this Registration Statement
(Form S-8) pertaining to the Signify Health, Inc. 2021 Long-Term Incentive Plan of our report dated August 2, 2023 relating to the unaudited
condensed consolidated interim financial statements of CVS Health Corporation that are included in its Form 10-Q for the quarter ended
June 30, 2023.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">/s/ Ernst &amp; Young LLP</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Boston, Massachusetts</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>ss2300944_ex2301.htm
<DESCRIPTION>CONSENT OF ERNST & YOUNG LLP
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0; text-align: center; background-color: white"><B>Consent of Independent
Registered Public Accounting Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; background-color: white">We consent to the
incorporation by reference in this Registration Statement (Form S-8) pertaining to the Signify Health, Inc. 2021 Long-Term Incentive
Plan of our reports dated February 8, 2023 (except for Note 8 and Note 18, as to which the date is May 25, 2023), with respect to the
consolidated financial statements of CVS Health Corporation and the effectiveness of internal control over financial reporting of CVS
Health Corporation included in its Current Report on Form 8-K dated May 25, 2023, filed with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 80%; border-bottom: black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ernst &amp; Young LLP</FONT></TD>
    <TD STYLE="width: 20%; font: 11pt Calibri, Helvetica, Sans-Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Boston, Massachusetts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">August 2, 2023</P>

<P STYLE="font: 11pt/11.75pt Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ss2300944_ex9901.htm
<DESCRIPTION>SIGNIFY HEALTH, INC. 2021 LONG-TERM INCENTIVE PLAN
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: right; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"><B>&nbsp;EXHIBIT
99.1&nbsp;</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: center; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: center; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"><B>SIGNIFY
HEALTH, INC.</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.4pt 27pt 0 0.5in; text-align: center; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"><B>2021
LONG-TERM INCENTIVE PLAN</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.4pt 27pt 0 0.5in; text-align: center; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"><B>(As
Amended July 28, 2023)</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.3pt 27pt 0 0.5in; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
1. <I>Purpose</I>. The purpose of the Signify Health, Inc. 2021 Long-Term Incentive Plan (as amended from time to time, the &#8220;<B>Plan</B>&#8221;)
is to motivate and reward employees and other individuals to perform at the highest level and contribute significantly to the success
of CVS Health Corporation (the &#8220;<B>Company</B>&#8221;), thereby furthering the best interests of the Company and its stockholders.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 1.95pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 1.95pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
2. <I>Definitions</I>. Certain capitalized terms applicable to the Plan are set forth in Appendix&nbsp;A.</FONT></P>

<P STYLE="font: 11pt/21.6pt Times New Roman, Times, Serif; margin: 1.95pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
3. <I>Administration</I>.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 1.95pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Administration of the Plan</I>. The Plan shall be administered by the Committee. All decisions of the Committee shall be final,
conclusive and binding upon all parties, including the Company, its stockholders, Eligible Persons and any Beneficiaries thereof. The
Committee may issue rules and regulations for the administration of the Plan.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.4pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Composition of Committee</I>. To the extent necessary or desirable to comply with applicable regulatory regimes, any action
by the Committee shall require the approval of Committee members who are (i) independent, within the meaning of and to the extent required
by applicable rulings and interpretations of the applicable stock market or exchange on which Shares are quoted or traded; and (ii) non-employee
Directors within the meaning of Rule 16b-3 under the Exchange Act. The Board may designate one or more Directors as alternate members
of the Committee who may replace any absent or disqualified member at any meeting of the Committee. To the extent permitted by applicable
law, including under Section 157(c) of the Delaware General Corporation Law, the Committee may delegate to one or more officers of the
Company some or all of its authority under the Plan, including the authority to grant Awards (except that such delegation shall not be
applicable to any Award for a Person then covered by Section 16 of the Exchange Act), and the Committee may delegate to one or more committees
of the Board (which may consist of solely one Director) some or all of its authority under the Plan, including the authority to grant
all types of Awards, in accordance with applicable law.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.4pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Authority of Committee</I>. Subject to the terms of the Plan and applicable law, the Committee (or its delegate) shall have
full discretion and authority to: (i) designate Eligible Persons; (ii) determine the type or types of Awards (including Substitute Awards)
to be granted to each Eligible Person under the Plan; (iii) determine the number of Shares to be covered by (or with respect to which
payments, rights or other matters are to be calculated in connection with) Awards; (iv) determine the terms and conditions of any Award
and prescribe the form of each Award Agreement which need not be identical for each Participant; (v) determine whether, to what extent
and under what circumstances Awards may be settled or exercised in cash, Shares, other Awards, other property, net settlement, or any
combination thereof, or canceled, forfeited or suspended, and the method or methods by which Awards may be settled, exercised, canceled,
forfeited or suspended; (vi) determine whether, to what extent and under what circumstances cash, Shares, other Awards, other property
and other amounts payable with respect to an Award under the Plan shall be deferred either automatically or at the election of the holder
thereof or of the Committee; (vii) amend terms or conditions of any outstanding Awards; (viii) correct any defect, supply any omission
and reconcile any inconsistency in the Plan or any Award, in the manner and to the extent it shall deem desirable to carry the Plan into
effect; (ix) interpret and administer the Plan and any instrument or agreement relating to, or Award made under, the Plan; (x) establish,
amend, suspend or waive such rules and regulations and appoint such agents, trustees, brokers, depositories and advisors and determine
such terms of their engagement as it shall deem appropriate for the proper administration of the Plan and due compliance with applicable
law, stock market or exchange rules and regulations or accounting or tax rules and regulations; and (xi) make any other determination
and take any other action that the Committee deems necessary or desirable for the administration of the Plan and due compliance with
applicable law, stock market or exchange rules and regulations or accounting or tax rules and regulations. Notwithstanding anything to
the contrary contained herein, the Board may, in its sole discretion, at any time and from time to time, grant Awards or administer the
Plan. In any such case, the Board shall have all of the authority and responsibility granted to the Committee herein.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-bottom: 0"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-bottom: 0"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-bottom: 0"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
4. <I>Participation</I>. Consistent with the purposes of the Plan, the Committee shall have exclusive power to select the Eligible Persons
who may participate in the Plan and be granted Awards under the Plan. Eligible Persons may be selected individually or by groups or categories,
as determined by the Committee in its discretion.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.45pt 27pt 0 0.5in; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
5. &nbsp;&nbsp;<I>Shares Available for Award.</I></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 5.85pt 27pt 12pt 0.5in; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Share Reserve</I>.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0.05pt 27pt 0 0.5in; text-align: justify; text-indent: 45pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to adjustment as provided in Section 5(b) and except for Substitute Awards, the maximum number of Shares available for
issuance under the Plan shall not exceed 9,234,836 Shares (the &#8220;<B>Share Reserve</B>&#8221;). The maximum number of Shares available
for issuance with respect to Incentive Stock Options shall be 9,234,836.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0.05pt 27pt 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0.05pt 27pt 0 0.5in; text-align: justify; text-indent: 45pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Shares subject to Awards that are forfeited or cancelled or otherwise expire for any reason without having been exercised or settled
will be added back to the Share Reserve. Notwithstanding the foregoing, the following Shares will not be added back to the Share Reserve:
(i) Shares not issued or delivered as a result of net settlement of an outstanding Option or Stock Appreciation Right; (ii) Shares delivered
or withheld by the Company to pay the exercise price of or the withholding taxes with respect to an Award; and (iii) Shares repurchased
with proceeds from the payment of the exercise price of an Option. Any Award settled solely in cash will not count against the Share
Reserve.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 45pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Shares issued pursuant to the Plan may be either authorized but unissued shares, treasury shares, reacquired shares or any combination
thereof.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.4pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Adjustments</I>. In the event that the Committee determines that, as a result of any dividend or other distribution (other
than an ordinary dividend or distribution), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation,
separation, rights offering, split-up, spin-off, combination, repurchase or exchange of Shares or other securities of the Company, issuance
of warrants or other rights to purchase Shares or other securities of the Company, issuance of Shares pursuant to the anti-dilution provisions
of securities of the Company, or other similar corporate transaction or event affecting Shares, or changes in applicable laws, regulations
or accounting principles, an adjustment is appropriate in order to prevent dilution or enlargement of the benefits or potential benefits
intended to be made available under the Plan, then the Committee shall, subject to compliance with Section 409A of the Code and other
applicable law, adjust equitably so as to ensure no undue enrichment or harm (including, without limitation, by payment of cash) any
or all of:</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify; text-indent: 45pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the number and type of Shares (or other securities) which thereafter may be made the subject of Awards, including the aggregate
limits specified in Section 5(a);</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify; text-indent: 45pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the number and type of Shares (or other securities) subject to outstanding Awards;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify; text-indent: 45pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the grant, purchase, exercise or hurdle price with respect to any Award or, if deemed appropriate, make provision for a cash payment
to the holder of an outstanding Award; and</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.5pt 27.35pt 0 0.5in; text-align: justify; text-indent: 45.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the terms and conditions of any outstanding Awards, including the performance criteria of any Performance Awards.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"><I>provided</I>,
<I>however</I>, that the number of Shares subject to any Award denominated in Shares shall always be a whole number.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 27pt 0 0.5in; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 27pt 0 0.5in; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
6. <I>Awards under the Plan</I>.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.8pt 27pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Types of Awards</I>. Awards under the Plan may include, but need not be limited to, one or more of the following types, either
alone or in any combination thereof: (i) Options, (ii) Stock Appreciation Rights, (iii) Restricted Stock, (iv) Restricted Stock Units,
(v) Performance Awards, (vi) Other Cash-Based Awards and (vii) Other Stock-Based Awards.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.4pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Rights with Respect to Shares and Other Securities</I>. Except as provided in Section 9(c) with respect to Awards of Restricted
Stock and unless otherwise determined by the Committee in its discretion, a Participant to whom an Award is made (and any Person succeeding
to such a Participant&#8217;s rights pursuant to the Plan) shall have no rights as a stockholder with respect to any Shares or as a holder
with respect to other securities, if any, issuable pursuant to any such Award until the date a stock certificate evidencing such Shares
or other evidence of ownership is issued to such Participant or until Participant&#8217;s ownership of such Shares shall have been entered
into the books of the registrar in the case of uncertificated shares.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Award Agreements.</I> Each Award granted or sold under the Plan shall be evidenced by an Award Agreement in such form as the
Committee shall prescribe from time to time in accordance with the Plan and shall comply with the applicable terms and conditions of
the Plan and applicable law, and with such other terms and conditions, including, but not limited to, treatment of the Award upon a Separation
from Service and restrictions upon the Option or the Shares issuable upon exercise thereof, as the Committee, in its discretion, shall
establish.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
7. <I>Options</I>. The Committee may grant Options to Eligible Persons with the following terms and conditions and with such additional
terms and conditions, in each case, not inconsistent with the provisions of the Plan, as the Committee shall determine; <I>provided</I>
that an Incentive Stock Option may be granted only to Eligible Persons who are employees of Signify Health or any subsidiary of Signify
Health within the meaning of Sections 424(e) and (f) of the Code, including a subsidiary which becomes such after adoption of the Plan.</FONT></P>

<P STYLE="font: 11pt/2pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee shall determine the number of Shares to be subject to each Option and the exercise price per Share subject to each
Option. Except in the case of Substitute Awards, the exercise price of an Option shall not be less than the Fair Market Value of a Share
subject to such Option on the date of grant, as determined by the Committee; <I>provided, however</I>, if an Incentive Stock Option is
granted to a Ten Percent Employee, such exercise price shall not be less than 110% of such Fair Market Value at the time the Option is
granted.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Any Option may be exercised during its term only at such time or times and in such installments as the Committee may establish.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 5.85pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>An Option shall not be exercisable:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 5.85pt 27pt 0 0.5in; text-align: justify; text-indent: 44.65pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in the case of any Incentive Stock Option granted to a Ten Percent Employee, after the expiration of five years from the date
it is granted, and, in the case of any other Option, after the expiration of ten years from the date it is granted; and</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 5.85pt 27pt 0 0.5in; text-align: justify; text-indent: 44.65pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>no Shares shall be issued unless payment in full is made for the Shares being acquired under such Option at the time of exercise
as provided in Section 7(e).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.45pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the case of an Incentive Stock Option, the amount of the aggregate Fair Market Value of Shares (determined at the time of grant
of the Option) with respect to which Incentive Stock Options are exercisable for the first time by an employee of Signify Health or a
subsidiary during any calendar year (under all such plans of his or her employer corporation and its parent and subsidiary corporations
within the meaning of Sections 424(e) and (f) of the Code) shall not exceed $100,000 or such other amount as is specified in the Code.
An Incentive Stock Option that is exercised at a time that is beyond the time an Incentive Stock Option may be exercised in order to
qualify as such under the Code shall cease to be an Incentive Stock Option.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee shall determine the method or methods by which, and the form or forms in which payment of the exercise price with
respect thereto may be made or deemed to have been made, including cash, Shares, other Awards, other property, net settlement, broker-assisted
cashless exercise or any combination thereof, having a Fair Market Value on the exercise date equal to the exercise price of the Shares
as to which the Option shall be exercised. The Committee may provide in the applicable Award Agreement that, to the extent an Option
is not previously exercised as to all of the Shares subject thereto, and, if the Fair Market Value of one Share is greater than the exercise
price then in effect, then the Option shall be deemed automatically exercised immediately before its expiration.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No grant of Options may be accompanied by a tandem award of dividend equivalents or provide for dividends, dividend equivalents
or other distributions to be paid on such Options.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the exercise of an Option is prevented by Section 20(f), the Option shall remain exercisable until thirty days after the date
such exercise first would no longer be prevented by such provision, but in any event no later than the expiration date of such Option.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.4pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
8. <I>Stock Appreciation Rights</I>. The Committee may grant Stock Appreciation Rights to Eligible Persons with the following terms and
conditions, and with such additional terms and conditions in each case not inconsistent with the provisions of the Plan, as the Committee
shall determine.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Stock Appreciation Rights may be granted under the Plan to Eligible Persons either alone or in addition to other Awards granted
under the Plan and may, but need not, relate to a specific Option granted under Section 7.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.4pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee shall determine the number of Shares to be subject to each Award of Stock Appreciation Rights and the exercise or
hurdle price per Share subject to each Stock Appreciation Right. Except in the case of Substitute Awards, Stock Appreciation Rights shall
have an exercise or hurdle price no less than the Fair Market Value of the Shares subject to such Stock Appreciation Right on the date
of grant, as determined by the Committee.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any Stock Appreciation Right may be exercised during its term only at such time or times and in such installments as the Committee
may establish and shall not be exercisable after the expiration of ten years from the date it is granted.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.4pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>An Award of Stock Appreciation Rights shall entitle the holder to exercise such Award and to receive from the Company in exchange
thereof, without payment to the Company, that number of Shares or cash or some combination thereof having an aggregate value equal to
the excess of the Fair Market Value of one Share, at the time of such exercise, over the exercise or hurdle price, times the number of
Shares subject to the Award, or portion thereof, that is so exercised or surrendered, as the case may be. The Committee may provide in
the applicable Award Agreement that, to the extent a Stock Appreciation Right is not previously exercised as to all of the Shares subject
thereto, and, if the Fair Market Value of one Share is greater than the exercise or hurdle price then in effect, then the Stock Appreciation
Right shall be deemed automatically exercised immediately before its expiration.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No grant of Stock Appreciation Rights may be accompanied by a tandem award of dividend equivalents or provide for dividends, dividend
equivalents or other distributions to be paid on such Stock Appreciation Rights.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.25pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the exercise of a Stock Appreciation Right is prevented by Section 20(f), the Stock Appreciation Right shall remain exercisable
until thirty days after the date such exercise first would no longer be prevented by such provision, but in any event no later than the
expiration date of such Stock Appreciation Right.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 0 27.35pt 0 0.5in; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 0 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
9. <I>Restricted Stock and Restricted Stock Units</I>. The Committee is authorized to grant Awards of Restricted Stock and Restricted
Stock Units to Eligible Persons with the following terms and conditions and with such additional terms and conditions, in each case not
inconsistent with the provisions of the Plan, as the Committee shall determine.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.4pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee shall determine the number of Shares to be issued to a Participant pursuant to the Award of Restricted Stock or
Restricted Stock Units, and the extent, if any, to which they shall be issued in exchange for cash, other consideration, or both. The
Award Agreement shall specify the vesting schedule and such other applicable conditions and restrictions and, with respect to Restricted
Stock Units, shall specify the delivery schedule (which may include deferred delivery later than the vesting date).</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.4pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Until the expiration of such period as the Committee shall determine from the date on which the Award is granted and subject to
such other terms and conditions as the Committee, in its discretion, shall establish (the &#8220;<B>Restricted Period</B>&#8221;), a
Participant to whom an Award of Restricted Stock is made shall be issued, but shall not be entitled to the delivery of, a stock certificate
or other evidence of ownership representing the Shares subject to such Award.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.4pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Unless otherwise determined by the Committee in its discretion, a Participant to whom an Award of Restricted Stock has been made
(and any Person succeeding to such a Participant&#8217;s rights pursuant to the Plan) shall have, after issuance of a certificate for
the number of Shares awarded (or after the Participant&#8217;s ownership of such Shares shall have been entered into the books of the
registrar in the case of uncertificated shares) and prior to the expiration of the Restricted Period, ownership of such Shares, including
the right to vote such Shares and to receive dividends or other distributions made or paid with respect to such Shares, <I>provided </I>that,
such Shares, and any new, additional or different shares, or other Company securities or property, or other forms of consideration that
the Participant may be entitled to receive with respect to such Shares as a result of a stock split, stock dividend or any other change
in the corporation or capital structure of the Company, shall be subject to the restrictions set forth in the Award and the Plan. A Restricted
Stock Unit shall not convey to the Participant the rights and privileges of a stockholder with respect to the Shares subject to the Restricted
Stock Unit, such as the right to vote or the right to receive dividends, unless and until a Share is issued to the Participant to settle
the Restricted Stock Unit.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.4pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee may, in its discretion, specify in the applicable Award Agreement that any or all dividends, dividend equivalents
or other distributions, as applicable, paid on Awards of Restricted Stock or Restricted Stock Units prior to vesting or settlement, as
applicable, be paid either in cash or in additional Shares and either on a current or deferred basis and that such dividends, dividend
equivalents or other distributions may be reinvested in additional Shares, which may be subject to the same restrictions as the underlying
Awards. Notwithstanding the foregoing, dividends and dividend equivalents with respect to Restricted Stock and Restricted Stock Units
shall vest only if and to the extent that the underlying Award vests.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.4pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee may determine the form or forms (including cash, Shares, other Awards, other property or any combination thereof)
in which payment of the amount owing upon settlement of any Restricted Stock Unit may be made.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.4pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee may provide in an Award Agreement that an Award of Restricted Stock is conditioned upon the Participant making or
refraining from making an election with respect to the Award under Section 83(b) of the Code. If a Participant makes an election pursuant
to Section 83(b) of the Code with respect to an Award of Restricted Stock, such Participant shall be required to file within the time
period required by Section 83(b) of the Code a copy of such election with the Company and the applicable Internal Revenue Service office.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
10. <I>Performance Awards</I>. The Committee is authorized to grant Performance Awards to Participants with the following terms and conditions
and with such additional terms and conditions, in either case not inconsistent with the provisions of the Plan, as the Committee shall
determine:</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Performance Awards may be denominated as a cash amount, number of Shares or units or a combination thereof, and may be earned
upon achievement or satisfaction of performance conditions specified by the Committee (including, without limitation, cash flow, earnings
(including EBITDA or some variation thereof), earnings per share, debt, return on investment, stock price, total or relative increases
to stockholder return, operating income or net operating income, gross margin, operating margin or profit margin, and other financial
or non-financial operating and management performance objectives). The Committee may use such business criteria and other measures of
performance as it may deem appropriate in establishing any performance conditions. Subject to the terms of the Plan, the performance
goals to be achieved during any Performance Period, the length of any Performance Period, the amount of any Performance Award granted
and the amount of any payment or transfer to be made pursuant to any Performance Award shall be determined by the Committee.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Performance criteria may be measured on an absolute (<I>e.g.</I>, plan or budget) or relative basis, and may be established on
a corporate-wide basis, with respect to one or more business units, divisions, Subsidiaries or business segments, or on an individual
basis. If the Committee determines that a change in the business, operations, corporate structure or capital structure of the Company,
or the manner in which the Company conducts its business, or other events or circumstances render the performance objectives unsuitable,
the Committee may modify the performance objectives or the related minimum acceptable level of achievement, in whole or in part, as the
Committee deems appropriate and equitable such that it does not provide any undue enrichment or harm. Performance measures may vary from
Performance Award to Performance Award and from Participant to Participant, and may be established on a stand-alone basis, in tandem
or in the alternative. The Committee shall have the power to impose such other restrictions on Awards subject to this Section 10(b) as
it may deem necessary or appropriate to ensure that such Awards satisfy all requirements of any applicable law, stock market or exchange
rules and regulations or accounting or tax rules and regulations.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.4pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Performance Awards may be settled in cash, Shares, other Awards, other property, or any combination thereof, and at such times,
as determined in the discretion of the Committee.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee may, in its discretion, specify in the applicable Award Agreement that any or all dividends, dividend equivalents
or other distributions, as applicable, paid on Awards of Restricted Stock or Restricted Stock Units prior to vesting or settlement, as
applicable, be paid either in cash or in additional Shares and either on a current or deferred basis and that such dividends, dividend
equivalents or other distributions may be reinvested in additional Shares, which may be subject to the same restrictions as the underlying
Awards. Notwithstanding the foregoing, dividends and dividend equivalents with respect to Restricted Stock and Restricted Stock Units
that are granted as Performance Awards shall vest only if and to the extent that the underlying Performance Award vests, as determined
by the Committee.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A Performance Award shall not convey to a Participant the rights and privileges of a stockholder with respect to any Shares subject
to such Performance Award, such as the right to vote (except as relates to Restricted Stock) or the right to receive dividends, unless
and until and to the extent Shares are issued to such Participant to settle such Performance Award. The Committee may, in its discretion,
specify in the applicable Award Agreement that any or all dividends, dividend equivalents or other distributions, as applicable, paid
on a Performance Award during the period that such Performance Award is outstanding, be paid either in cash or in additional Shares and
either on a current or deferred basis and that such dividends, dividend equivalents or other distributions may be reinvested in additional
Shares, which may be subject to the same restrictions as the underlying Awards. For the avoidance of doubt, unless otherwise determined
by the Committee, no dividend equivalent rights shall be provided with respect to any Shares subject to Performance Awards that are not
earned or otherwise do not vest or settle pursuant to their terms.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee may, in its discretion, increase or reduce the amount of a settlement otherwise to be made in connection with a
Performance Award.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
11. <I>Other Cash-Based Awards and Other Stock-Based Awards</I>. The Committee may grant Other Cash-Based Awards (either independently
or as an element of or supplement to any other Award under the Plan) and Other Share-Based Awards to Eligible Persons with the following
terms and conditions and with such additional terms and conditions, in each case not inconsistent with the provisions of the Plan, as
the Committee shall determine, which shall consist of any right that is (i) not an Award described in Sections 7 through 10 above and
(ii) an Award of Shares or cash or an Award denominated or payable in, valued in whole or in part by reference to, or otherwise based
on or related to, Shares (including, without limitation, securities convertible into Shares), as deemed by the Committee to be consistent
with the purposes of the Plan. Subject to the terms of the Plan and any applicable Award Agreement, the Committee shall determine the
terms and conditions of any such Other Cash-Based Award or Other Share-Based Award.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.5pt 27pt 0 0; text-indent: 0.5in"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
12. <I>Minimum Vesting Requirements</I>. Notwithstanding anything to the contrary herein and subject to Section 13, Awards granted (a)
prior to the Acquisition Date shall vest over a period of not less than one year following the date of grant and (b) on or after the
Acquisition Date shall vest over a minimum period of three years following the date of grant (such requirements, the &#8220;<B>Minimum
Vesting Requirements</B>&#8221;); <I>provided</I>, <I>however</I>, that (i) subject to clause (ii) of this Section 12, all Awards granted
on or after the Acquisition Date that either the grant or the vesting is based on the achievement of one or more performance conditions
will vest over a minimum period of one year and (ii) the Committee may, in its sole discretion, (A) accelerate the vesting of Awards
or otherwise lapse or waive the Minimum Vesting Requirements upon (1) the Participant&#8217;s death or disability or (2) a Change in
Control (subject to the requirements of Section 12) and (B) grant Awards that are not subject to the Minimum Vesting Requirements with
respect to 5% or less of the Shares available for issuance under the Plan.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
13. <I>Effect of Separation from Service or a Change in Control on Awards</I>.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.8pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee may provide, by rule or regulation or in any applicable Award Agreement, or may determine in any individual case,
the circumstances in which, and the extent to which, an Award may be exercised, settled, vested, paid or forfeited in the event of the
Participant&#8217;s Separation from Service prior to the end of a Performance Period or vesting, exercise or settlement of such Award.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee may determine, in its discretion, whether, and the extent to which, (i) an Award will vest during a leave of absence,
(ii) a reduction in service level (for example, from full-time to part-time employment) will cause a reduction, or other change, to an
Award and (iii) a leave of absence or reduction in service will be deemed a Separation from Service, in each case subject to the provisions
of Section 409A.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event of a Change in Control, the Committee may, in its sole discretion, and on such terms and conditions as it deems appropriate,
take any one or more of the following actions with respect to any outstanding Award, which need not be uniform with respect to all Participants
and/or Awards:</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.4pt 27pt 0 0.5in; text-align: justify; text-indent: 31.5pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>continuation or assumption of such Award by the Company (if it is the surviving entity) or by the successor or surviving corporation
or its parent;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.4pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>substitution or replacement of such Award by the successor or surviving entity or its parent with cash, securities, rights or
other property to be paid or issued, as the case may be, by the successor or surviving entity (or a parent or subsidiary thereof), with
substantially the same terms and value as such Award (including, without limitation, any applicable performance targets or criteria with
respect thereto);</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>acceleration of the vesting of such Award and the lapse of any restrictions thereon and, in the case of an Option or Stock Appreciation
Right, acceleration of the right to exercise such Award during a specified period (and the termination of such Option or Stock Appreciation
Right without payment of any consideration therefor to the extent such Award is not timely exercised), in each case, either (A) immediately
prior to or as of the date of the Change in Control, (B) upon the Participant&#8217;s involuntary Separation from Service (including
upon a termination of the Participant&#8217;s employment by the Company (or a successor entity or its parent)) on or within a specified
period following such Change in Control or (C) upon the failure of the successor or surviving entity (or its parent) to continue or assume
such Award;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in the case of a Performance Award, determination of the level of attainment of the applicable performance condition(s); and</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.85pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>cancellation of such Award in consideration of a payment, with the form, amount and timing of such payment determined by the Committee
in its sole discretion, subject to the following: (A) such payment shall be made in cash, securities, rights and/or other property; (B)
the amount of such payment shall equal the value of such Award, as determined by the Committee in its sole discretion; <I>provided </I>that,
in the case of an Option or Stock Appreciation Right, if such value equals the Intrinsic Value of such Award, such value shall be deemed
to be valid; <I>provided further</I> that, if the Intrinsic Value of an Option or Stock Appreciation Right is equal to or less than zero,
the Committee may, in its sole discretion, provide for the cancellation of such Award without payment of any consideration therefor (for
the avoidance of doubt, in the event of a Change in Control, the Committee may, in its sole discretion, terminate any Option or Stock
Appreciation Right for which the exercise or hurdle price is equal to or exceeds the per Share value of the consideration to be paid
in the Change in Control transaction without payment of consideration therefor); and (C) such payment shall be made promptly following
such Change in Control or on a specified date or dates following such Change in Control; <I>provided </I>that the timing of such payment
shall comply with Section 409A.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.85pt 27pt 0 0.5in; text-align: justify; text-indent: 31.5pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding Section 13(c) to the contrary, with respect to Awards granted on or after the Acquisition Date, in the event that
a Participant experiences a Termination Without Cause or a Constructive Termination Without Cause within two years following a Change
in Control, the following provisions shall apply unless otherwise provided in the Award Agreement: (i) within two years of a Change in
Control, any Award carrying a right to exercise that was not previously exercisable and vested shall become fully exercisable and vested
upon a Termination Without Cause or a Constructive Termination Without Cause and shall remain exercisable and vested for the balance
of the stated term of such Award without regard to any termination of employment by the Participant; (ii) within two years of a Change
in Control, the restrictions, deferral of settlement and forfeiture conditions applicable to any other Award granted under the Plan shall
lapse and such Awards shall be deemed fully vested upon a Termination Without Cause or a Constructive Termination Without Cause, except
to the extent of any waiver by the Participant; and (iii) with respect to any outstanding Award subject to achievement of performance
goals and conditions under the Plan, such performance goals and other conditions will be deemed to be met at actual performance or prorated
as of the date of termination, provided that, with respect to each of clause (i) and (ii), in connection with a Change in Control, the
Company shall take or cause to be taken no action, and shall undertake or permit to arise no legal or contractual obligation, that results
or would result in any postponement of the issuance or delivery of Shares or payment of benefits under any Award or the imposition of
any other conditions on such issuance, delivery or payment, to the extent that such postponement or other condition would represent a
greater burden on a Participant than existed on the 90th day preceding the Change in Control.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
14. <I>Section 409A</I>. Notwithstanding any provision of the Plan or an Award Agreement to the contrary, if any Award provided under
the Plan is subject to the provisions of Section 409A, the provisions of the Plan and any applicable Award Agreement shall be administered,
interpreted and construed in a manner necessary in order to comply with Section 409A or an exception thereto (or disregarded to the extent
such provision cannot be so administered, interpreted or construed), and the following provisions shall apply, as applicable and as required
by Section 409A:</FONT></P>

<P STYLE="font: 9pt/104% Times New Roman, Times, Serif; margin: 5.4pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="font-size: 11pt; letter-spacing: normal; line-height: normal; word-spacing: normal">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 11pt; letter-spacing: normal; line-height: normal; word-spacing: normal">If a Participant is a &#8220;specified
employee&#8221; under Section 409A and a payment subject to Section 409A (and not excepted therefrom) to the Participant is due upon
Separation from Service, such payment shall be delayed for a period of six months after the date the Participant Separates from Service
(or, if earlier, the death of the Participant). Any payment that would otherwise have been due or owing during such six-month period
will be paid immediately following the end of the six-month period unless another compliant date is specified in the applicable agreement.
If an Award includes a &#8220;series of installment payments&#8221; (within the meaning of Treas. Reg. &sect; 1.409A-2(b)(2)(iii)), a
Participant&#8217;s right to such series of installment payments shall be treated as a right to a series of separate payments and not
as a right to a single payment, and if an Award includes &#8220;dividend equivalents&#8221; (within the meaning of Treas. Reg. &sect;
1.409A-3(e)), a Participant&#8217;s right to such dividend equivalents shall be treated separately from the right to other amounts under
the Award.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For purposes of Section 409A, and to the extent applicable to any Award under the Plan, it is intended that distribution events
qualify as permissible distribution events for purposes of Section 409A and shall be interpreted and construed accordingly. Whether a
Participant has Separated from Service will be determined by the Committee based on all of the facts and circumstances and, to the extent
applicable to any Award, in accordance with the guidance issued under Section 409A.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The grant of Nonqualified Stock Options, Stock Appreciation Rights and other stock rights subject to Section 409A are intended
to be granted under terms and conditions consistent with Treas. Reg. &sect; 1.409A-1(b)(5) such that any such Award does not constitute
a deferral of compensation under Section 409A.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
15. <I>Deferred Payment of Awards</I>. The Committee, in its discretion, may specify the conditions under which the payment of all or
any portion of any cash compensation, or Shares or other form of payment under an Award, may be deferred until a later date. Deferrals
shall be for such periods or until the occurrence of such events, and upon such terms and conditions, as the Committee shall determine
in its discretion, in accordance with the provisions of Section 409A; <I>provided</I>, <I>however</I>, that no deferral shall be permitted
with respect to Options or Stock Appreciation Rights.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
16. <I>Transferability of Awards</I>. Except pursuant to the laws of descent and distribution, a Participant&#8217;s rights and interest
under the Plan or any Award may not be assigned or transferred, hypothecated or encumbered in whole or in part, including, but not by
way of limitation, execution, levy, garnishment, attachment, pledge, bankruptcy or in any other manner; <I>provided</I>, <I>however</I>,
the Committee may permit such transfer to a Permitted Transferee; and <I>provided</I>, <I>further</I>, that, unless otherwise permitted
by the Code, any Incentive Stock Option granted pursuant to the Plan shall not be transferable other than by will or by the laws of descent
and distribution, and shall be exercisable during the Participant&#8217;s lifetime only by a Participant.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
17. <I>Amendment or Substitution of Awards under the Plan</I>.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.85pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The terms of any outstanding Award under the Plan may be amended or modified from time to time after grant by the Committee in
its discretion in any manner that it deems appropriate (including, but not limited to, acceleration of the date of exercise of any Award
and/or payments under any Award) in accordance with the terms of the Plan. Subject to Section 5(b) and Section 13, no such amendments
or acceleration shall adversely affect in a material manner any right of a Participant under the Award without his or her written consent,
except (x) to the extent necessary to conform the provisions of the Award with Section 409A or any other provision of the Code or other
applicable law, stock market or exchange rules and regulations or accounting or tax rules and regulations, or (y) to impose any &#8220;clawback&#8221;
or recoupment provisions on any Awards (including any amounts or benefits arising from such Awards) in accordance with Section 20(o).
The Committee may, in its discretion, permit holders of Awards under the Plan to surrender outstanding Awards in order to exercise or
realize the rights under other Awards, or in exchange for the grant of new Awards, or require holders of Awards to surrender outstanding
Awards as a condition precedent to the grant of new Awards under the Plan.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>No Repricing</I>. Notwithstanding the foregoing, except as provided in Section 5(b), no action shall directly or indirectly,
through cancellation and regrant or any other method, reduce, or have the effect of reducing, the exercise or hurdle price of any &#8220;out
of the money&#8221; Award established at the time of grant thereof without approval of the Company&#8217;s stockholders, including (i)
amending or modifying the terms of the Award to lower the exercise or hurdle price; (ii) cancelling the Award and granting either (A)
replacement Options, Stock Appreciation Rights or similar Awards having a lower exercise or hurdle price or (B) Restricted Stock, Restricted
Stock Units, Performance Awards or Other Share-Based Awards in exchange; or (iii) cancelling or repurchasing the out of the money Options,
Stock Appreciation Rights or similar Awards for cash or other securities.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.3pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 0 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
18. <I>Termination of a Participant</I>. For all purposes under the Plan, the Committee shall determine whether a Participant has Separated
from Service, terminated employment with, or terminated the performance of services for, the Company or any subsidiary (including Signify
Health); <I>provided, however</I>, an absence or leave approved by the Company, to the extent permitted by applicable provisions of the
Code, shall not be considered an interruption of employment or performance of services for any purpose under the Plan.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
19. <I>Designation of Beneficiary by Participant</I>. A Participant may name a beneficiary to receive any payment to which such Participant
may be entitled with respect to any Award under the Plan in the event of his or her death, on a written form to be provided by and filed
with the Committee, and in a manner determined by the Committee in its discretion (a &#8220;<B>Beneficiary</B>&#8221;). The Committee
reserves the right to review and approve Beneficiary designations. A Participant may change his or her Beneficiary from time to time
in a manner determined by the Committee in its discretion, unless such Participant has made an irrevocable designation. Any designation
of a Beneficiary under the Plan (to the extent it is valid and enforceable under applicable law) shall be controlling over any other
disposition, testamentary or otherwise, as determined by the Committee in its discretion. If no designated Beneficiary survives the Participant
and is living on the date on which any amount becomes payable to such a Participant&#8217;s Beneficiary, such payment will be made to
the legal representatives of the Participant&#8217;s estate, and the term &#8220;<B>Beneficiary</B>&#8221; as used in the Plan shall
be deemed to include such Person or Persons. If there are any questions as to the legal right of any Beneficiary to receive a distribution
under the Plan, the Committee in its discretion may determine that the amount in question be paid to the legal representatives of the
estate of the Participant, in which event the Company, the Board, the Committee, the designated administrator (if any), and the members
thereof, will have no further liability to anyone with respect to such amount.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
20. <I>Miscellaneous Provisions</I>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 5.8pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any proceeds from Awards shall constitute general funds of the Company.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.85pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No fractional Shares may be delivered under an Award, but in lieu thereof a cash or other adjustment may be made as determined
by the Committee in its discretion.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.4pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Eligible Person or other Person shall have any claim or right to be granted an Award under the Plan. Determinations made by
the Committee under the Plan need not be uniform and may be made selectively among Eligible Persons under the Plan, whether or not such
Eligible Persons are similarly situated. Neither the Plan nor any action taken under the Plan shall be construed as giving any Eligible
Person any right to continue to be employed by or perform services for the Company, and the Company specifically reserves the right to
terminate the employment of, or performance of services by, Eligible Persons at any time and for any reason.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Participant or other Person shall have any right with respect to the Plan or the Shares reserved for issuance under the Plan
or in any Award, contingent or otherwise, until written evidence of the Award shall have been delivered to the Participant and all the
terms, conditions and provisions of the Plan and the Award applicable to such Participant (and each Person claiming under or through
him or her) have been met.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No payment pursuant to the Plan shall be taken into account in determining any benefits under any severance, pension, retirement,
savings, profit sharing, group insurance, welfare or other benefit plan of the Company or any Affiliate, except to the extent otherwise
expressly provided in writing in such other plan or an agreement thereunder.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.4pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything to the contrary contained in the Plan or in any Award agreement, each Award shall be subject to the requirement,
if at any time the Committee shall determine, in its sole discretion, that such requirement shall apply, that the listing, registration
or qualification of any Award under the Plan, or of the Shares, other Company securities or property or other forms of payment issuable
pursuant to any Award under the Plan, on any stock exchange or other market quotation system or under any federal or state law, or the
consent or approval of any government regulatory body, is necessary or desirable as a condition of, or in connection with, the granting
of such Award or the exercise or settlement thereof, such Award shall not be granted, exercised or settled in whole or in part until
such listing, registration, qualification, consent or approval shall have been effected, obtained and maintained free of any conditions
not acceptable to the Committee. Notwithstanding anything to the contrary contained in the Plan or in any Award agreement, no Shares,
other Company securities or property or other forms of payment shall be issued under the Plan with respect to any Award unless the Committee
shall be satisfied that such issuance will be in compliance with applicable law and any applicable rules of any stock exchange or other
market quotation system on which such Shares are listed. If the Committee determines that the exercise of any Option or Stock Appreciation
Right would fail to comply with any applicable law or any applicable rules of any stock exchange or other market quotation system on
which Shares are listed, the Participant holding such Option or Stock Appreciation Right shall have no right to exercise such Option
or Stock Appreciation Right until such time as the Committee shall have determined that such exercise will not violate any applicable
law or any such applicable rule.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Although it is the intent of Company that the Plan and Awards hereunder, to the extent the Committee deems appropriate and to
the extent applicable, comply with Rule 16b-3 and Sections 409A and 422; (i) the Company does not warrant that any Award under the Plan
will qualify for favorable tax treatment under any provision of federal, state, local or non-United States law; and (ii) in no event
shall any member of the Committee or the Company (or its employees, officers or directors) have any liability to any Participant (or
any other Person) due to the failure of an Award to satisfy the requirements of Rule 16b-3 or Section 409A or 422 or, as applicable,
for any tax, interest, or penalties the Participant might owe as a result of the grant, holding, vesting, exercise, or payment of any
Award under the Plan.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company shall have the right to deduct from any payment made under the Plan any federal, state, local or foreign income or
other taxes required by law to be withheld with respect to such payment. It shall be a condition to the obligation of Company to issue
Shares, other securities or property, or other forms of payment, or any combination thereof, upon exercise, settlement or payment of
any Award under the Plan, that the Participant (or any Beneficiary or Person entitled to act) pay to Company, upon its demand, such amount
as may be required by the Company for the purpose of satisfying any liability to withhold federal, state, local or foreign income or
other taxes. If the amount requested is not paid, the Company may refuse to issue Shares, other securities or property, or other forms
of payment, or any combination thereof.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Notwithstanding anything in this Plan to the contrary, the Committee may, in its discretion,
permit an Eligible Person (or any Beneficiary or Person entitled to act) to elect to pay a portion or all of the amount requested by
the Company for such taxes with respect to such Award, at such time and in such manner as the Committee shall deem to be appropriate
(including, but not limited to, by authorizing the Company to withhold, or agreeing to surrender to the Company on or about the date
such tax liability is determinable, Shares, other securities or property, or other forms of payment, or any combination thereof, owned
by such Person or a portion of such forms of payment that would otherwise be distributed, or have been distributed, as the case may be,
pursuant to such Award to such Person, having a market value equal to the amount of such taxes); <I>provided, however</I>, that any broker-assisted
cashless exercise shall comply with the requirements of Financial Accounting Standards Board, Accounting Standards Codification, Topic
718, and any withholding satisfied through a net-settlement of an Award shall be limited to the maximum statutory withholding requirements.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The expenses of the Plan shall be borne by the Company; <I>provided, however</I>, the Company may recover from a Participant or
his or her Beneficiary, heirs or assigns any and all damages, fees, expenses and costs incurred by the Company arising out of any actions
taken by a Participant in breach of the Plan or any applicable Award Agreement.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Plan shall be unfunded. The Company shall not be required to establish any special or separate fund or to make any other segregation
of assets to assure the payment of any Award under the Plan, and rights to the payment of Awards shall be no greater than the rights
of the Company&#8217;s general creditors.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>By accepting any Award or other benefit under the Plan, each Participant (and each Person claiming under or through him or her)
shall be conclusively deemed to have indicated his or her acceptance and ratification of, and consent to, any action taken under the
Plan by the Company, the Board, the Committee or the designated administrator (if applicable).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 5.4pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Records of the Company shall be conclusive for all purposes under the Plan or any Award, unless determined by the Committee to
be incorrect.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.85pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If any provision of the Plan or any Award is held to be illegal or invalid for any reason, the illegality or invalidity shall
not affect the remaining provisions of the Plan or any Award, but such provision shall be fully severable, and the Plan or Award, as
applicable, shall be construed and enforced as if the illegal or invalid provision had never been included in the Plan or Award, as applicable.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.4pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The terms of the Plan shall govern all Awards under the Plan and in no event shall the Committee have the power to grant any Award
under the Plan that is contrary to any of the provisions of the Plan.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee may specify in an Award Agreement that a Participant&#8217;s rights, payments and benefits with respect to an Award
shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain specified events, in addition to
any otherwise applicable vesting or performance conditions of an Award. Such events may include a Separation from Service with or without
&#8220;cause&#8221; (and, in the case of any &#8220;cause&#8221; that is resulting from an indictment or other non-final determination,
the Committee may provide for such Award to be held in escrow or abeyance until a final resolution of the matters related to such event
occurs, at which time the Award shall either be reduced, cancelled or forfeited (as provided in such Award Agreement) or remain in effect,
depending on the outcome), violation of material policies, breach of non-competition, non-solicitation, confidentiality or other restrictive
covenants, or requirements to comply with minimum share ownership requirements, that may apply to the Participant, or other conduct by
the Participant that is detrimental to the business or reputation of the Company and/or its Affiliates. The Committee shall have full
authority to implement any policies and procedures necessary to comply with Section 10D of the Exchange Act and any rules promulgated
thereunder and any other regulatory regimes.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Notwithstanding anything to the contrary contained herein, any Awards granted under the
Plan (including any amounts or benefits arising from such Awards) shall be subject to any clawback or recoupment arrangements or policies
the Company or any of its Affiliates have in place from time to time, and the Committee may, to the extent permitted by applicable law
and stock exchange rules or by any applicable Company policy or arrangement, and shall, to the extent required, cancel or require reimbursement
of any Awards granted to the Participant or any Shares issued or cash received upon vesting, exercise or settlement of any such Awards
or sale of Shares underlying such Awards.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee may from time to time establish sub-plans under the Plan for purposes of satisfying securities, tax or other laws
of various jurisdictions in which the Company intends to grant Awards. Any sub-plans shall contain such limitations and other terms and
conditions as the Committee determines are necessary or desirable. All sub-plans shall be deemed a part of the Plan, but, if applicable,
each sub-plan shall apply only to the Participants in the jurisdiction for which the sub-plan was designed. Awards may be granted to
Participants who are non-United States nationals or employed or providing services outside the United States, or both, on such terms
and conditions different from those applicable to Awards to Participants who are employed or providing services in the United States
as may, in the judgment of the Committee, be necessary or desirable to recognize differences in local law, tax policy or custom.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.5pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All certificates, if any, for Shares and/or other securities delivered under the Plan pursuant to any Award or the exercise or
settlement thereof shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the
Plan or the rules, regulations and other requirements of the Securities and Exchange Commission, any stock market or exchange upon which
such Shares or other securities are then quoted, traded or listed, and any applicable securities laws, and the Committee may cause a
legend or legends to be put on any such certificates to make appropriate reference to such restrictions.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(r)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company will not be obligated to deliver any Shares under the Plan or remove restrictions from Shares previously delivered
under the Plan until (i) all Award conditions have been met or removed to the Committee&#8217;s satisfaction, (ii) as determined by the
Committee, all other legal matters regarding the issuance and delivery of such Shares have been satisfied, including any applicable securities
laws, stock market or exchange rules and regulations or accounting or tax rules and regulations and (iii) the Participant has executed
and delivered to the Company such representations or agreements as the Committee deems necessary or appropriate to satisfy any applicable
laws. The Company&#8217;s inability to obtain authority from any regulatory body having jurisdiction, which the Committee determines
is necessary to the lawful issuance and sale of any Shares, will relieve the Company of any liability for failing to issue or sell such
Shares as to which such requisite authority has not been obtained.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(s)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Committee may impose restrictions on any Award with respect to non-competition, non-solicitation, confidentiality and other
restrictive covenants, or requirements to comply with minimum share ownership requirements, as it deems necessary or appropriate in its
sole discretion, which such restrictions may be set forth in any applicable Award Agreement or otherwise.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
21. <I>Effective Date</I>. The Plan shall be effective on the Effective Date, <I>provided</I> that the Board and the Company&#8217;s
stockholders may approve the Plan prior to such date.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
22. <I>Amendment or Termination</I>.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.8pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Plan Amendment or Termination</I>. Except to the extent prohibited by applicable law, the Plan may be amended, suspended, discontinued
or terminated in whole or in part at any time and/or from time to time by the Committee; <I>provided that</I> no such amendment, suspension,
discontinuation or termination shall be made without stockholder approval if such approval is necessary to qualify for or comply with
any tax or regulatory requirement, other applicable law or the rules of the stock market or exchange, if any, on which the Shares are
principally quoted or traded for which the Committee deems it necessary or desirable to qualify or comply. No amendment of the Plan shall
adversely affect in a material manner any right of any Participant with respect to any Award previously granted without such Participant&#8217;s
written consent, except as permitted under Section 5(b) and Section 13.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"></FONT></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.8pt 27pt 0 0.5in; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Notwithstanding the foregoing or any provision of the Plan to
the contrary, the Committee may at any time (without the consent of any Participant) modify, amend or terminate any or all of the provisions
of the Plan to the extent necessary to conform the provisions of the Plan with Section 409A or any other provision of the Code or other
applicable law, the regulations issued thereunder or an exception thereto, regardless of whether such modification, amendment or termination
of the Plan shall adversely affect the rights of a Participant.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Dissolution or Liquidation</I>. In the event of the dissolution or liquidation of the Company, each Award shall terminate immediately
prior to the consummation of such action, unless otherwise determined by the Committee.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.45pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
23. <I>Term of the Plan</I>. No Awards shall be granted under the Plan after earlier of the following dates or events to occur:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 5.8pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>upon the adoption of a resolution of the Board terminating the Plan;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 5.8pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the tenth anniversary of the Effective Date; or</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 5.8pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the maximum number of Shares available for issuance under the Plan has been issued.</FONT></P>

<P STYLE="font: 11pt/2pt Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">However,
unless otherwise expressly provided in the Plan or in an applicable Award Agreement, any Award theretofore granted may extend beyond
such date, and the authority of the Committee to amend, alter, adjust, suspend, discontinue or terminate any such Award, or to waive
any conditions or rights under any such Award, and the authority of the Committee to amend the Plan, shall extend beyond such date.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.5pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">Section
24. <I>Governing Law</I>. The Plan and any Award granted under the Plan as well as any determinations made or actions taken under the
Plan shall be governed by, and construed and enforced in accordance with, the internal laws of the State of Delaware without regard to
its choice or conflicts of laws principles.</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/2pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/2pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt/2pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt/2pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: center"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"><B>APPENDIX
A</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.3pt 27pt 0 0.5in; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">The
following terms shall have the meaning indicated:</FONT></P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0.3pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/103% Times New Roman, Times, Serif; margin: 0 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Acquisition
Date</B>&#8221; means March 29, 2023.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Affiliate</B>&#8221;
means any entity that, directly or indirectly through one or more intermediaries controls, is controlled by or is under common control
with, the Company.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Award</B>&#8221;
means an award of Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Awards, Other Cash- Based
Awards or Other Stock-Based Awards under the Plan.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Award
Agreement</B>&#8221; means any agreement, contract or other instrument or document (including in electronic form) evidencing any Award
granted under the Plan, which may, but need not, be executed or acknowledged by a Participant.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Beneficial
Owner</B>&#8221; has the meaning ascribed to such term in Rule 13d-3 under the Exchange Act.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Beneficiary</B>&#8221;
has the meaning set forth in Section 19.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Board</B>&#8221;
means the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Cause</B>&#8221;
shall be deemed to occur, solely with respect to Awards granted on or following the Acquisition Date, if the Participant (a) willfully
and materially breaches any of his or her obligations to the Company or Signify Health with respect to confidentiality, cooperation with
regard to litigation, non-disparagement and non-solicitation, (b) is convicted of a felony involving moral turpitude or (c) engages in
conduct that constitutes willful gross neglect or willful gross misconduct in carrying our Participant&#8217;s duties to the Company
or Signify Health, resulting, in either case, in material harm to the financial condition or reputation of the Company or Signify Health.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Change
in Control</B>&#8221; means, unless otherwise defined in an Award Agreement prior to the Acquisition Date, the occurrence of any of the
following: (i) any Person (other than (w) the Company, (x) any trustee or other fiduciary holding securities under any employee benefit
plan of the Company, (y) any corporation owned, directly or indirectly, by the stockholders of the Company immediately after the occurrence
with respect to which the evaluation is being made in substantially the same proportions as their ownership of the common stock of the
Company immediately prior to such occurrence, or (z) any surviving or resulting entity from a merger or consolidation referred to in
clause (iii) below) becomes the Beneficial Owner (except that a Person shall be deemed to be the Beneficial Owner of all shares that
any such Person has the right to acquire pursuant to any agreement or arrangement or upon exercise of conversion rights, warrants or
options or otherwise, without regard to the 60 day period referred to in Rule 13d-3 under the Exchange Act), as directly or indirectly,
of securities of the Company or of any subsidiary owning directly or indirectly all or substantially all of the consolidated assets of
the Company (a &#8220;<B><U>Significant Subsidiary</U></B>&#8221;), representing 30% or more of the combined voting power of the Company&#8217;s
or such Significant Subsidiary&#8217;s then outstanding securities; (ii) during any period of 12 consecutive months, individuals who
at the beginning of such period constitute the Board, and any new director whose election by the Board or nomination for election by
the Company&#8217;s stockholders was approved by a vote of at least a majority of the directors then still in office who either were
directors at the beginning of the 12-month period or whose election or nomination for election was previously so approved, cease for
any reason to constitute at least a majority of the Board; (iii) the consummation of a merger or consolidation of the Company or any
Significant Subsidiary with any other entity, other than a merger or consolidation which would result in the voting securities of the
Company or a Significant Subsidiary outstanding immediately prior thereto continuing to represent (either by remaining outstanding or
by being converted into voting securities of the surviving or resulting entity) more than 50% of the combined voting power of the surviving
or resulting entity outstanding immediately after such merger or consolidation; or (iv) the consummation of a transaction (or series
of transactions within a 12-month period) which constitutes the sale or disposition of all or substantially all of the consolidated assets
of the Company but in no event assets having a gross fair market value of less than 40% of the total gross fair market value of all of
the consolidated assets of the Company (other than such a sale or disposition immediately after which such assets will be owned directly
or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the common stock of the
Company immediately prior to such sale or disposition).</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"></FONT></P>

<!-- Field: Page; Sequence: 15; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Code</B>&#8221;
shall mean the Internal Revenue Code of 1986, as it now exists or may be amended from time to time, and the rules and regulations promulgated
thereunder, as they may exist or may be amended from time to time.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Committee</B>&#8221;
shall mean the compensation committee of the Board unless another committee is designated by the Board. If there is no compensation committee
of the Board and the Board does not designate another committee, references herein to the &#8220;Committee&#8221; shall refer to the
Board.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Constructive
Termination Without Cause</B>&#8221; means, solely with respect to Awards granted on or following the Acquisition Date, the Participant&#8217;s
termination of his or her employment following the occurrence, without the Participant&#8217;s written consent, of one or more of (i)
an assignment of any duties to the Participant that is materially inconsistent with the Participant&#8217;s position; (ii) a material
decrease in the Participant&#8217;s annual base salary or target annual incentive award opportunity; or (iii) a relocation of the Participant&#8217;s
principal place of employment more than 35 miles from the Participant&#8217;s place of employment before such relocation. In all cases,
no Constructive Termination Without Cause shall be deemed to have occurred if any such event occurs as a result of a prior termination.
In addition, no Constructive Termination Without Cause shall be deemed to have occurred unless the Participant provides written notice
to the Company that any such event has occurred, which notice identifies the event and is provided within 30 days of the initial occurrence
of such event, a cure period of 45 days following the Company&#8217;s receipt of such notice expires and the Company has not cured such
event within such cure period, and the Participant actually terminates his or her employment within 30 days of the expiration of the
cure period.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Consultant</B>&#8221;
means any individual, including an advisor, who is providing services to the Company or any Subsidiary or who has accepted an offer of
service or consultancy from the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Director</B>&#8221;
means any member of the Board.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Effective
Date</B>&#8221; means the date on which the registration statement covering the initial public offering of Signify Health common shares
was declared effective by the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Eligible
Person(s)</B>&#8221; means those persons who are (i) full or part-time employees or Consultants of Signify Health or any subsidiary or
(ii) other individuals who perform services for Signify Health or any subsidiary, in each case to the extent that an offer or receipt
of an Award to such person is permitted by applicable law and stock market or exchange rules and regulations.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Exchange
Act</B>&#8221; means the Securities Exchange Act of 1934, as it now exists or may be amended from time to time, and the rules promulgated
thereunder, as they may exist or may be amended from time to time.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Fair
Market Value</B>&#8221; means, except as otherwise determined by the Committee, with respect to Awards granted prior to the Acquisition
Date, (i) with respect to the Shares, as of any date, (A) if the Company&#8217;s Shares are listed on any established stock exchange,
system or market, the closing market price of a Share as quoted in such exchange, system or market on the applicable date of determination
(or, if such date is not a trading day, the trading day immediately preceding such date of determination) as reported in the Wall Street
Journal or such other source as the Committee deems reliable or (B) in the absence of an established market for the Shares, as determined
in good faith by the Committee or (ii) with respect to property other than Shares, the value of such property, as determined by the Committee,
in its sole discretion. For Awards granted on or after the Acquisition Date, unless otherwise determined by the Committee, the Fair Market
Value of Shares shall be the closing price of a Share, as quoted on the composite transactions table on the New York Stock Exchange,
on the date on which the determination of Fair Market Value is being made, or, in the event the date on which the determination is being
made is a date on which the New York Stock Exchange is closed, then the closing price of a Share, as quoted on the composite transactions
table on the New York Stock Exchange on the last date prior to such date on which the New York Stock Exchange was open, shall be used.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"></FONT></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Incentive
Stock Option</B>&#8221; means an Option that is an incentive stock option as defined in Section 422 of the Code.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Intrinsic
Value</B>&#8221; with respect to an Option or Stock Appreciation Right means (i) the excess, if any, of the price or implied price per
Share in a Change in Control or other event <I>over </I>(ii) the exercise or hurdle price of such Award <I>multiplied by </I>(iii) the
number of Shares covered by such Award.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Non-Qualified
Stock Option</B>&#8221; means an Option that is not an Incentive Stock Option.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Option</B>&#8221;
means an Incentive Stock Option or a Non-Qualified Stock Option.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Other
Cash-Based Award</B>&#8221; means an Award granted pursuant to Section 11, including cash awarded as a bonus or upon the attainment of
specified performance criteria or otherwise as permitted under the Plan.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Other
Stock-Based Award</B>&#8221; means an Award granted pursuant to Section 11 that may be denominated or payable in, valued in whole or
in part by reference to, or otherwise based on, or related to, Shares or factors that may influence the value of Shares, including convertible
or exchangeable debt securities, other rights convertible or exchangeable into Shares, purchase rights for Shares, dividend rights or
dividend equivalent rights or Awards with a value and payment contingent upon performance of the Company or business units thereof or
any other factors designated by the Committee.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Participant</B>&#8221;
means an Eligible Person to whom an Award has been granted under the Plan.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Performance
Award</B>&#8221; means an Award subject, in part, to the terms, conditions and restrictions described in Section 10, pursuant to which
the recipient may become entitled to receive cash, Shares or other securities or property issuable under the Plan, or any combination
thereof, as determined by the Committee.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Performance
Period</B>&#8221; means the period established by the Committee with respect to any Performance Award during which the performance goals
specified by the Committee with respect to such Award are to be measured.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Permitted
Transferee</B>&#8221; means (i) any person defined as an employee in the Instructions to Registration Statement Form S-8 promulgated
by the Securities and Exchange Commission, as such form may be amended from time to time, which persons include, as of the date of adoption
of the Plan, executors, administrators or beneficiaries of the estates of deceased Participants, guardians or members of a committee
for incompetent former Participants, or similar persons duly authorized by law to administer the estate or assets of former Participants,
and (ii) Participants&#8217; family members who acquire Awards from the Participant other than for value, including through a gift or
a domestic relations order. For purposes of this definition, &#8220;<B>family member</B>&#8221; includes any child, stepchild, grandchild,
parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law,
brother-in-law, or sister-in-law, including adoptive relationships, any person sharing the Participant&#8217;s household (other than
a tenant or employee), a trust in which these persons have more than fifty percent of the beneficial interest, a foundation in which
these persons (or the Participant) control the management of assets, and any other entity in which these persons (or the Participant)
own more than fifty percent of the voting interests. For purposes of this definition, neither (i) a transfer under a domestic relations
order in settlement of marital property rights, nor (ii) a transfer to an entity in which more than fifty percent of the voting or beneficial
interests are owned by family members (or the Participant) in exchange for an interest in that entity is considered a transfer for &#8220;value&#8221;.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Person</B>&#8221;
has the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections 13(d) and 14(d) thereof, including
a &#8220;group&#8221; as defined in Section 13(d) thereof.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Restricted
Period</B>&#8221; has the meaning set forth in Section 9(b).</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Restricted
Stock</B>&#8221; means an Award of Shares that are issued subject, in part, to the terms, conditions and restrictions described in Section
9.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"></FONT></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 11pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27.35pt 0 0.5in; text-align: justify; text-indent: 27.35pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Restricted
Stock Units</B>&#8221; means an Award of the right to receive either (as the Committee determines) Shares or cash equal to the Fair Market
Value of a Share on the payment date, issued subject, in part, to the terms, conditions and restrictions described in Section 9.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Rule
16b-3</B>&#8221; means Rule 16b-3 promulgated by the Securities and Exchange Commission under the Exchange Act and any successor rule.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Section
409A</B>&#8221; means Section 409A of the Code, any rules or regulations promulgated thereunder, as they may exist or may be amended
from time to time, or any successor to such section.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Section
422</B>&#8221; means Section 422 of the Code, any rules or regulations promulgated thereunder, as they may exist or may be amended from
time to time, or any successor to such section.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Separation
from Service</B>&#8221; and &#8220;<B>Separate from Service</B>&#8221; means the Participant&#8217;s death, retirement or other termination
of employment or service with the Company (including all persons treated as a single employer under Sections 414(b) and 414(c) of the
Code) that constitutes a &#8220;separation from service&#8221; (within the meaning of Section 409A).</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Share
Reserve</B>&#8221; has the meaning set forth in Section 5(a)(i).</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Shares</B>&#8221;
means shares of common stock, par value $0.01 per share, of the Company.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Signify
Health</B>&#8221; means Signify Health, Inc.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Stock
Appreciation Right</B>&#8221; means an Award of a right to receive (without payment to the Company) cash, Shares or other property, or
other forms of payment, or any combination thereof, as determined by the Committee, based on the increase in the Fair Market Value of
the number of Shares specified in the Stock Appreciation Right. Stock Appreciation Rights are subject, in part, to the terms, conditions
and restrictions described in Section 8.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Substitute
Award</B>&#8221; means an Award granted in assumption of, or in substitution for, an outstanding award previously granted by a company
or other business acquired by the Company or with which the Company combines.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Ten
Percent Employee</B>&#8221; means an employee of the Company or any subsidiary who owns stock representing more than ten percent of the
voting power of all classes of stock of the Company or any parent or subsidiary of the Company within the meaning of Sections 424(e)
and (f) of the Code.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin: 5.05pt 27pt 0 0.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&#8220;<B>Termination
Without Cause</B>&#8221; means the involuntary termination of a Participant&#8217;s employment by the Company or a subsidiary, including
Signify Health, without Cause.</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: center"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">A-4&nbsp;</FONT></P>

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt/104% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: justify"><FONT STYLE="letter-spacing: normal; line-height: normal; word-spacing: normal">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>6
<FILENAME>ss2300944_ex1071.htm
<DESCRIPTION>CALCULATION OF FILING FEE TABLE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">Exhibit 107.1</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 5.75pt 6pt 5.05pt; text-align: center"><B>CALCULATION OF FILING FEE TABLE</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 5.75pt 6pt 5.05pt; text-align: center"><B>S-8</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 5.75pt 6pt 5.05pt; text-align: center">(Form Type)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 5.75pt 6pt 5.05pt; text-align: center"><B>CVS Health Corporation<BR>
</B>(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 5.75pt 6pt 5.05pt; text-align: center"><U>Table 1: Newly Registered Securities</U></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Security
    Type</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 10%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Security
    Class Title</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 13%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Fee
    Calculation Rule</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 12%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Amount
    Registered</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 11%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Proposed
    Maximum Offering Price Per Unit</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 14%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Maximum
    Aggregate Offering Price</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 12%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Fee
    Rate</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 18%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Amount
    of Registration Fee</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Common
    Stock, $0.01 par value per share</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Other</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">9,234,836
    (1)(2)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">$74.38
    (3)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">$686,887,102
    (3)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">0.00011020</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">$75,694.96
    (3)</FONT></TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Total
    Offering Amounts</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">$686,887,102</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">$75,694.96</FONT></TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Total
    Fee Offsets</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">N/A</FONT></TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Net
    Fee Due</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">$75,694.96</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">This Registration Statement on Form S-8 relates to 9,234,836 shares of common stock, par value $0.01 per
share (&ldquo;<B>Common Stock</B>&rdquo;), of CVS Health Corporation (the &ldquo;<B>Company</B>&rdquo; or the &ldquo;<B>Registrant</B>&rdquo;).
In connection with the Agreement and Plan of Merger, dated as of September 2, 2022 (the &ldquo;<B>Merger Agreement</B>&rdquo;) by CVS
Pharmacy, Inc. (the &ldquo;<B>Parent</B>&rdquo;), a Rhode Island corporation and wholly-owned subsidiary of the Company, with Signify
Health, Inc., a Delaware corporation (&ldquo;<B>Signify Health</B>&rdquo;) and Noah Merger Sub, Inc., a Delaware corporation and wholly-owned
subsidiary of the Parent (the &ldquo;<B>Merger Subsidiary</B>&rdquo;), such shares reserved and available for issuance pursuant to future
awards under the <FONT STYLE="background-color: white">Signify Health, Inc. 2021 Long-Term Incentive Plan (the &ldquo;<B>Plan</B>&rdquo;)</FONT>
were converted from shares of class A common stock, par value $0.01 per share, of Signify Health into shares of Common Stock immediately
prior to the effective time of the merger, whereby Signify Health became a wholly-owned subsidiary of the Company (the &ldquo;<B>Merger</B>&rdquo;),
and adjusted pursuant to the exchange ratio in accordance with the terms of the Merger Agreement.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">Pursuant to Rule 416(a) under the Securities Act of 1933 (the &ldquo;<B>Securities Act</B>&rdquo;), this
Registration Statement also covers any additional shares of Common Stock that become issuable under the Plan by any reason of any stock
dividend, stock split, or other similar transaction.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">Estimated solely for the purpose of calculating
the registration fee in accordance with Rule 457(c) and (h) under the Securities Act based o<FONT STYLE="background-color: white">n a
price of $74.38 per share of Common Stock, which is the average of the high and low price per share of Common Stock as reported by the
</FONT>New York Stock Exchange <FONT STYLE="background-color: white">on August 1, 2023.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="border-top: Black 2pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  , /<# 2(  A$! Q$!_\0
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M9YW[><GUJMJ7A^RO[WQJ)S*?M4,+-A@-K(I*E>."#6MJ<7]I_"^2*ZD=_.L
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MNJ3%KZPU*)HWR?WT#1DHWOCI^%=IXQ6+7/'MEX?U/SGT:'3I+^:WC8@7#!L
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?8> ]*M8BQCCC8 L<G[[44 ?_V0$!              $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
